Investors pile in as Cordance secures oversubscribed seed round for brain-cancer tech
The fresh capital will propel Cordance into its first-in-human clinical trial
The fresh capital will propel Cordance into its first-in-human clinical trial
Deceased donor kidney transplants are time-critical, and it is uncommon to attempt them robotically
Abbott is eyeing to become a global powerhouse in early cancer detection and precision oncology
A key highlight will be Brenntag’s qualified amino acids portfolio
The deal accelerates GE HealthCare’s digital transformation, expanding its reach into outpatient care and enterprise imaging—a $2 billion-plus growth market
The partnership combines Croda’s deep expertise in smart science and global market reach with Amino’s advanced capabilities in precision manufacturing of amino acids
Winlevi is authorized in EU for the treatment of acne vulgaris
HER2-mutant NSCLC typically has a poor prognosis and limited treatment options
The X CUBE 50 integrates ALPINION’s advanced X+ Architecture
Subscribe To Our Newsletter & Stay Updated